Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma
Figure 9.Drug susceptibility analysis associated with ARHGAP39. (A) Pathway analyses were studied by GSCA Lite website. (B) We used the GSCA Lite website to display drug susceptibility with five genes (C) Interacting chemicals of ARHGAP39 from CTD.